# Tadalafil 5 mg on Storage Lower Urinary Tract Symptoms After Anatomical Endoscopic Enucleation of the Prostate

> **NCT07466030** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Assiut University** · enrollment: 40 (estimated)

## Conditions studied

- BPH (Benign Prostatic Hyperplasia)

## Interventions

- **DRUG:** Tadalafil 5mg (Male)
- **DRUG:** Omiga 3

## Key facts

- **NCT ID:** NCT07466030
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2028-03-01
- **Final completion:** 2028-09-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07466030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07466030, "Tadalafil 5 mg on Storage Lower Urinary Tract Symptoms After Anatomical Endoscopic Enucleation of the Prostate". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07466030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*